178 related articles for article (PubMed ID: 25338674)
1. Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experience.
Petric R; Gazic B; Besic N
BMC Cancer; 2014 Oct; 14():777. PubMed ID: 25338674
[TBL] [Abstract][Full Text] [Related]
2. Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: a single-institution experience.
Besic N; Schwarzbartl-Pevec A; Vidergar-Kralj B; Crnic T; Gazic B; Marolt Music M
BMC Cancer; 2016 Feb; 16():162. PubMed ID: 26921186
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy in 29 patients with locally advanced follicular or Hürthle cell thyroid carcinoma: a phase 2 study.
Besic N; Auersperg M; Gazic B; Dremelj M; Zagar I
Thyroid; 2012 Feb; 22(2):131-7. PubMed ID: 22175241
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
5. Is patient's age a prognostic factor for follicular thyroid carcinoma in the TNM classification system?
Besic N; Zgajnar J; Hocevar M; Frkovic-Grazio S
Thyroid; 2005 May; 15(5):439-48. PubMed ID: 15929665
[TBL] [Abstract][Full Text] [Related]
6. Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?
Sugino K; Kameyama K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
Ann Surg Oncol; 2013 Sep; 20(9):2944-50. PubMed ID: 23616135
[TBL] [Abstract][Full Text] [Related]
7. Aggressiveness of therapy and prognosis of patients with Hürthle cell papillary thyroid carcinoma.
Besic N; Hocevar M; Zgajnar J; Petric R; Pilko G
Thyroid; 2006 Jan; 16(1):67-72. PubMed ID: 16487016
[TBL] [Abstract][Full Text] [Related]
8. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
9. Papillary thyroid carcinoma: factors influencing recurrence and survival.
Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
[TBL] [Abstract][Full Text] [Related]
10. Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience.
Oluic B; Paunovic I; Loncar Z; Djukic V; Diklic A; Jovanovic M; Garabinovic Z; Slijepcevic N; Rovcanin B; Micic D; Filipovic A; Zivaljevic V
BMC Cancer; 2017 May; 17(1):371. PubMed ID: 28545571
[TBL] [Abstract][Full Text] [Related]
11. The role of radioactive iodine in the treatment of Hürthle cell carcinoma of the thyroid.
Besic N; Vidergar-Kralj B; Frkovic-Grazio S; Movrin-Stanovnik T; Auersperg M
Thyroid; 2003 Jun; 13(6):577-84. PubMed ID: 12930602
[TBL] [Abstract][Full Text] [Related]
12. Papillary thyroid microcarcinoma: prognostic factors and treatment.
Besic N; Pilko G; Petric R; Hocevar M; Zgajnar J
J Surg Oncol; 2008 Mar; 97(3):221-5. PubMed ID: 18050283
[TBL] [Abstract][Full Text] [Related]
13. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
14. Variables predicting distant metastases in thyroid cancer.
Clark JR; Lai P; Hall F; Borglund A; Eski S; Freeman JL
Laryngoscope; 2005 Apr; 115(4):661-7. PubMed ID: 15805877
[TBL] [Abstract][Full Text] [Related]
15. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
16. Hürthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003.
Mills SC; Haq M; Smellie WJ; Harmer C
Eur J Surg Oncol; 2009 Mar; 35(3):230-4. PubMed ID: 18722077
[TBL] [Abstract][Full Text] [Related]
17. Differentiated thyroid cancer presenting initially with distant metastasis.
Shaha AR; Shah JP; Loree TR
Am J Surg; 1997 Nov; 174(5):474-6. PubMed ID: 9374217
[TBL] [Abstract][Full Text] [Related]
18. Medullary thyroid carcinoma in Hong Kong Chinese patients.
Chow SM; Chan JK; Tiu SC; Choi KL; Tang DL; Law SC
Hong Kong Med J; 2005 Aug; 11(4):251-8. PubMed ID: 16085941
[TBL] [Abstract][Full Text] [Related]
19. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
Shoup M; Stojadinovic A; Nissan A; Ghossein RA; Freedman S; Brennan MF; Shah JP; Shaha AR
J Am Coll Surg; 2003 Aug; 197(2):191-7. PubMed ID: 12892796
[TBL] [Abstract][Full Text] [Related]
20. Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data.
Kim WG; Kim TY; Kim TH; Jang HW; Jo YS; Park YJ; Kim SW; Kim WB; Shong M; Park DJ; Chung JH; Shong YK; Cho BY
Korean J Intern Med; 2014 May; 29(3):325-33. PubMed ID: 24851067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
